U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. HIZENTRA
  1. Approved Blood Products

HIZENTRA

STN:  BLS 125350
Proper Name: Immune Globulin Subcutaneous (Human), 20% Liquid
Tradename: HIZENTRA
Manufacturer: CSL Behring AG
Indication:

Indicated for the treatment of:

  • Primary immunodeficiency (PI) in adults and pediatric patients 2 years of age and older.
  • Maintenance therapy in adults with indicated for the treatment of: chronic inflammatory demyelinating polyneuropathy (CIDP).

Product Information

Supporting Documents

Back to Top